Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

2.

GMP Synthase Is Required for Virulence Factor Production and Infection by Cryptococcus neoformans.

Chitty JL, Tatzenko TL, Williams SJ, Koh YQ, Corfield EC, Butler MS, Robertson AA, Cooper MA, Kappler U, Kobe B, Fraser JA.

J Biol Chem. 2017 Feb 17;292(7):3049-3059. doi: 10.1074/jbc.M116.767533. Epub 2017 Jan 6.

PMID:
28062578
3.

Invasive Aspergillus Sinusitis in Human Immunodeficiency Virus Infection: Case Report and Review of the Literature.

Humphrey JM, Walsh TJ, Gulick RM.

Open Forum Infect Dis. 2016 Jul 26;3(3):ofw135. eCollection 2016 Sep. Review.

4.

Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia.

Nikolopoulos GK, Kostaki EG, Paraskevis D.

Infect Genet Evol. 2016 Dec;46:256-268. doi: 10.1016/j.meegid.2016.06.017. Epub 2016 Jun 7. Review.

PMID:
27287560
5.

Clinical profile of human immunodeficiency virus patients with opportunistic infections: A descriptive case series study.

Ramesh K, Gandhi S, Rao V.

Int J Appl Basic Med Res. 2015 May-Aug;5(2):119-23. doi: 10.4103/2229-516X.157166.

6.
7.

Comparative performance of the probable case definitions of dengue by WHO (2009) and the WHO-SEAR expert group (2011).

Nujum ZT, Thomas A, Vijayakumar K, Nair RR, Pillai MR, Indu PS, Sundar S, Gopakumar S, Mohan D, Sudheeshkumar TK.

Pathog Glob Health. 2014 Mar;108(2):103-10. doi: 10.1179/2047773214Y.0000000131. Epub 2014 Mar 10.

8.

Moving forward in HIV-associated cancer.

Gopal S, Achenbach CJ, Yanik EL, Dittmer DP, Eron JJ, Engels EA.

J Clin Oncol. 2014 Mar 20;32(9):876-80. doi: 10.1200/JCO.2013.53.1376. Epub 2014 Feb 18. No abstract available.

9.

The Haiti research-based model of international public health collaboration: the GHESKIO Centers.

Pape JW, Severe PD, Fitzgerald DW, Deschamps MM, Joseph P, Riviere C, Rouzier V, Johnson WD Jr.

J Acquir Immune Defic Syndr. 2014 Jan 1;65 Suppl 1:S5-9. doi: 10.1097/QAI.0000000000000031.

10.

Thirty years of the human immunodeficiency virus epidemic and beyond.

Younai FS.

Int J Oral Sci. 2013 Dec;5(4):191-9. doi: 10.1038/ijos.2013.76. Epub 2013 Oct 18. Review.

11.

Only your calamity: the beginnings of activism by and for people with AIDS.

Wright J.

Am J Public Health. 2013 Oct;103(10):1788-98. doi: 10.2105/AJPH.2013.301381. Epub 2013 Aug 15.

12.

Overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease HIV transmission in men who have sex with men.

Mayer KH, Wheeler DP, Bekker LG, Grinsztejn B, Remien RH, Sandfort TG, Beyrer C.

J Acquir Immune Defic Syndr. 2013 Jul;63 Suppl 2:S161-7. doi: 10.1097/QAI.0b013e318298700e.

13.

The HIV Epidemic: High-Income Countries.

Vermund SH, Leigh-Brown AJ.

Cold Spring Harb Perspect Med. 2012 May;2(5):a007195. doi: 10.1101/cshperspect.a007195. Review.

14.

A deep profiler's guide to cytometry.

Bendall SC, Nolan GP, Roederer M, Chattopadhyay PK.

Trends Immunol. 2012 Jul;33(7):323-32. doi: 10.1016/j.it.2012.02.010. Epub 2012 Apr 2. Review.

15.

Histopathologic diagnosis of fungal infections in the 21st century.

Guarner J, Brandt ME.

Clin Microbiol Rev. 2011 Apr;24(2):247-80. doi: 10.1128/CMR.00053-10. Review.

16.

The immunocompromised patient.

Mahon JL, Stiller CR.

Can Fam Physician. 1987 Feb;33:349-59.

17.

Epidemiology of HIV infection in large urban areas in the United States.

Hall HI, Espinoza L, Benbow N, Hu YW; Urban Areas HIV Surveillance Workgroup..

PLoS One. 2010 Sep 15;5(9):e12756. doi: 10.1371/journal.pone.0012756.

18.

Does HIV/AIDS have a biological impact on the risk of human papillomavirus-related cancers?

Strickler HD.

J Natl Cancer Inst. 2009 Aug 19;101(16):1103-5. doi: 10.1093/jnci/djp236. Epub 2009 Jul 31. No abstract available. Erratum in: J Natl Cancer Inst. 2009 Oct 7;101(19):1364.

19.

Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study.

Crum-Cianflone N, Hullsiek KH, Marconi V, Weintrob A, Ganesan A, Barthel RV, Fraser S, Agan BK, Wegner S.

AIDS. 2009 Jan 2;23(1):41-50. doi: 10.1097/QAD.0b013e328317cc2d.

20.

Accelerating harm reduction interventions to confront the HIV epidemic in the Western Pacific and Asia: the role of WHO (WPRO).

Mesquita F, Jacka D, Ricard D, Shaw G, Tieru H, Hu Y, Poundstone K, Salva M, Fujita M, Singh N.

Harm Reduct J. 2008 Aug 5;5:26. doi: 10.1186/1477-7517-5-26.

Supplemental Content

Support Center